Gilead Sciences Inc (GILD)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$109.50
Buy
$111.50
$-1.03 (-0.93%)
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.
Prices updated at 31 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 78.26 | 36.53 | 1.67 | 15.42 | 4,434m |
| 2023 | 76.04 | 32.49 | 20.89 | 38.71 | 10,496m |
| 2022 | 79.26 | 40.23 | 16.83 | 32.45 | 8,852m |
| 2021 | 75.82 | 39.76 | 22.80 | 41.49 | 11,329m |
| 2020 | 81.48 | 40.21 | 0.50 | 16.74 | 4,133m |
| 2019 | 79.18 | 41.60 | 23.99 | 33.67 | 7,559m |
| 2018 | 78.07 | 42.02 | 24.65 | 46.57 | 10,305m |
| 2017 | 83.26 | 54.10 | 17.73 | 61.03 | 15,933m |
| 2016 | 85.98 | 58.02 | 44.43 | 63.24 | 19,219m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 4.82 | 23.13 | 13.36 |
| 2024 | 4.08 | 1,026.33 | 11.51 |
| 2023 | 3.73 | 17.35 | 12.15 |
| 2022 | 3.99 | 32.52 | 11.15 |
| 2021 | 3.35 | 12.37 | 9.11 |
| 2020 | 3.17 | 59.45 | 8.32 |
| 2019 | 3.72 | 30.65 | 9.35 |
| 2018 | 3.69 | 51.27 | 9.33 |
| 2017 | 3.44 | 8.15 | 7.69 |
| 2016 | 3.16 | 6.65 | 5.53 |
| 2015 | 5.00 | 9.28 | 8.51 |
Price/Forward earnings (YTD)
13.91
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | 0.79 | 2.28 | 2.05 |
| 2023 | 9.04 | 25.71 | 13.00 |
| 2022 | 7.00 | 21.71 | 11.13 |
| 2021 | 9.13 | 31.70 | 14.33 |
| 2020 | 0.19 | 0.60 | 1.74 |
| 2019 | 8.60 | 24.53 | 12.76 |
| 2018 | 8.14 | 26.08 | 12.09 |
| 2017 | 7.27 | 23.53 | 10.39 |
| 2016 | 24.84 | 72.16 | 33.62 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 3.05 |
| 2023 | 2.72 |
| 2022 | 2.97 |
| 2021 | 3.23 |
| 2020 | 3.76 |
| 2019 | 2.74 |
| 2018 | 2.98 |
| 2017 | 3.44 |
| 2016 | 3.02 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
